FI810934L - Farmaceutiska produkter - Google Patents

Farmaceutiska produkter

Info

Publication number
FI810934L
FI810934L FI810934A FI810934A FI810934L FI 810934 L FI810934 L FI 810934L FI 810934 A FI810934 A FI 810934A FI 810934 A FI810934 A FI 810934A FI 810934 L FI810934 L FI 810934L
Authority
FI
Finland
Prior art keywords
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
FI810934A
Other languages
English (en)
Other versions
FI70670B (fi
FI70670C (fi
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI810934L publication Critical patent/FI810934L/fi
Publication of FI70670B publication Critical patent/FI70670B/fi
Application granted granted Critical
Publication of FI70670C publication Critical patent/FI70670C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI810934A 1980-03-31 1981-03-26 Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel FI70670C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US13537380 1980-03-31

Publications (3)

Publication Number Publication Date
FI810934L true FI810934L (fi) 1981-10-01
FI70670B FI70670B (fi) 1986-06-26
FI70670C FI70670C (fi) 1986-10-06

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810934A FI70670C (fi) 1980-03-31 1981-03-26 Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel

Country Status (30)

Country Link
JP (1) JPS56152415A (fi)
KR (1) KR860000841B1 (fi)
AR (1) AR225500A1 (fi)
AT (1) AT370996B (fi)
AU (1) AU541056B2 (fi)
BE (1) BE888209A (fi)
CA (1) CA1162479A (fi)
CH (1) CH647481A5 (fi)
CS (1) CS246051B2 (fi)
DD (1) DD157762A5 (fi)
DE (1) DE3112272A1 (fi)
DK (1) DK158564C (fi)
ES (1) ES8206545A1 (fi)
FI (1) FI70670C (fi)
FR (1) FR2480605A1 (fi)
GB (1) GB2074028B (fi)
GR (1) GR72769B (fi)
HU (1) HU183379B (fi)
IE (1) IE51070B1 (fi)
IL (1) IL62517A (fi)
IT (1) IT1170838B (fi)
LU (1) LU83270A1 (fi)
NL (1) NL8101531A (fi)
NO (1) NO156675C (fi)
NZ (1) NZ196519A (fi)
PH (1) PH17152A (fi)
PT (1) PT72774B (fi)
SE (1) SE455045B (fi)
SU (1) SU1056893A3 (fi)
ZA (1) ZA812084B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DK0929293T3 (da) * 1996-08-23 2004-02-02 Sequus Pharm Inc Liposomer indeholdende en cisplatinforbindelse
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
EP3773498B1 (en) 2018-03-29 2022-06-22 Project Pharmaceutics GmbH Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
DE3112272C2 (fi) 1990-09-27
GR72769B (fi) 1983-12-02
AU6816681A (en) 1981-10-08
JPS56152415A (en) 1981-11-26
NO811081L (no) 1981-10-01
IE51070B1 (en) 1986-09-17
NO156675B (no) 1987-07-27
IT1170838B (it) 1987-06-03
LU83270A1 (fr) 1981-10-29
ZA812084B (en) 1982-04-28
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
FR2480605A1 (fr) 1981-10-23
AR225500A1 (es) 1982-03-31
PT72774A (en) 1981-04-01
DE3112272A1 (de) 1982-04-29
HU183379B (en) 1984-04-28
FI70670B (fi) 1986-06-26
IL62517A0 (en) 1981-05-20
SE8101990L (sv) 1981-11-13
SU1056893A3 (ru) 1983-11-23
GB2074028B (en) 1983-09-21
KR830004849A (ko) 1983-07-20
JPS6360008B2 (fi) 1988-11-22
DK144281A (da) 1981-10-01
AT370996B (de) 1983-05-25
AU541056B2 (en) 1984-12-13
DD157762A5 (de) 1982-12-08
PT72774B (en) 1982-11-16
KR860000841B1 (ko) 1986-07-09
PH17152A (en) 1984-06-13
DK158564C (da) 1990-11-05
SE455045B (sv) 1988-06-20
FI70670C (fi) 1986-10-06
GB2074028A (en) 1981-10-28
NL8101531A (nl) 1981-10-16
IT8148090A0 (it) 1981-03-24
NZ196519A (en) 1983-06-17
ATA150481A (de) 1982-10-15
CH647481A5 (fr) 1985-01-31
BE888209A (fr) 1981-09-30
FR2480605B1 (fi) 1984-05-11
ES500869A0 (es) 1982-08-16
NO156675C (no) 1987-11-04
ES8206545A1 (es) 1982-08-16
CS246051B2 (en) 1986-10-16

Similar Documents

Publication Publication Date Title
FI821123A0 (fi) Lokalt anvaendbara farmaceutiska produkter
DK198582A (da) Formede cementagtige produkter
PT73686A (pt) Pharmaceutical formulation
FI814013L (fi) Foerpackning foer braeckliga produkter
BE887099A (nl) Farmaceutisch preparaat tegen acne
DK345682A (da) Pharmaceutiske expienser
FI810558L (fi) 2(1h)-pyridinonderivat deras framstaellning och dessa innehaollande farmaceutiska produkter
FI810056L (fi) Farmaceutiska foereningar
DK208784D0 (da) Farmaceutisk produkt
DE3279806D1 (de) Corpuscules containing medicaments
FI862590A0 (fi) Farmaceutiska produkter.
FI850455A0 (fi) Farmaceutiska produkter.
BR8101177A (pt) Conjunto de medicao
FI813412L (fi) 3-aminopropoxifenylderivat deras framstaellning och dessa innehaollande farmaceutiska produkter
DK116382A (da) Tobaksprodukt
FI810934L (fi) Farmaceutiska produkter
FI803846L (fi) Farmaceutiska produkter
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
ES529819A0 (es) Medicamento que contiene muzolimina
FI830399A0 (fi) Mjoeldryge-alkaloider, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
ES502737A0 (es) Mejoras en la fabricacion de capsulas de medicamento
FI822980A0 (fi) Furanokromonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
FI811880L (fi) Farmaceutiska bicykliska foereningar och kompositioner
FI801334A (fi) Saett foer vaermebehandling av keramiska produkter
FI813953L (fi) Bis-hydroxibenzylderivat deras framstaellningsfoerfaranden ochdessa innehaollande farmaceutiska produkter

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO